Answers are grounded in this paper and cite their sources.
Intracerebroventricular administration of corticotropin-releasing factor (CRF) produces elevations in mean arterial pressure and heart rate in conscious freely-moving rats. Pretreatment with the ganglionic blocker, chlorisondamine, completely prevents the CRF-induced cardiovascular changes. These results suggest that CRF acts within the brain to stimulate sympathetic nervous activity which in turn influences cardiovascular function.
No takes yet. Share an insight, caveat, or question.
Fisher et al. (1982) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: